Hypermobility II

Session Type: ACR Study Groups
Tuesday, November 8, 2011: 1:00 PM-2:00 PM
W474a (McCormick Place West)

Session Overview:
As rheumatologists become more aware of the significance of hypermobility and as patients’ expectations rise, there is a greater need for rheumatologists to equip themselves with new knowledge about the scientific basis, clinical features, treatment and natural history of hypermobility related syndromes.

Upon completion of this session, participants should be able to:

  • recognize the joint hypermobility syndrome from its characteristic features
  • observe how chronic pain is more disruptive than in fibromyalgia and rheumatoid arthritis
  • identify how cognitive behavioral theorapy can help patients to cope with chronic pain in joint hypermobility syndrome when analgesics do not
  • acknowledge moves within the international community to improve the quality and reproducibility of classification criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome type III

1:00 PM
Typical features of the Joint Hypermobility Syndrome (JHS) Including the "Typical JHS Face” and the Marfanoid Habitus
Jaime F. Bravo, San Juan de Dios Hospital, Santiago, Chile
1:15 PM
: Impairment and Impact of Pain in Females with Hypermobility Type of Ehlers-Danlos Syndrome: A Comparative Study with Fibromyalgia and Rheumatoid Arthritis Patients
Lies Rombaut, Ghent University, Ghent, Belgium
1:35 PM
Joint Hypermobility Syndrome and Cognitive Behavioral Interventions
H. Clare Daniel, University College London Hospitals NHS Foundation Trust, London, United Kingdom
1:55 PM
Statement from the Helsinki 2010 Meeting: Is Revision of Criteria for Joint Hypermobility Syndrome and Ehlers-Danlos Syndrome Hypermobility Type Indicated?
Rodney Grahame, University College Hospital, London, United Kingdom
See more of: ACR Study Groups

To see other sessions for this day, use the date buttons to the left.